Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Off-pump revascularization for significant left ventricular dysfunction.

Y Joseph Woo1, Todd J Grand, George P Liao

  • 1Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania School of Medicine, 6 Silverstein Pavilion 3400 Spruce St., Philadelphia, PA 19104, USA. wooy@uphs.upenn.edu

Asian Cardiovascular & Thoracic Annals
|July 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invited response letter.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Single Cell and Spatial Transcriptomics Identify Novel Immune-Stromal Interactions in Cardiac Allograft Vasculopathy.

Research square·2025
Same author

Glycidyl methacrylate and methacrylic anhydride characterization for silk fibroin methacrylation in tissue engineering.

Journal of materials chemistry. B·2025
Same author

Ex-vivo heart perfusion attenuates early post-transplant risk after prolonged agonal period in DCD heart transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Adult heart transplantation in the USA and Western Europe: state of the art review.

European heart journal·2025
Same author

Dual Contrast-Enhanced Microcomputed Tomography Uncovers Leaflet-Dependent Patterns of Macrocalcification, Fibrous Extracellular Matrix Remodeling, and Adipocyte Degeneration in Calcific Aortic Stenosis.

Journal of the American Heart Association·2025

Off-pump coronary artery bypass grafting (CABG) offers a safe revascularization alternative for patients with poor left ventricular function. This approach yields outcomes comparable to those with normal ventricular function, minimizing perioperative risks.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Heart Failure Research

Background:

  • Left ventricular dysfunction (LVD) significantly increases perioperative risks in traditional on-pump coronary artery bypass grafting (CABG).
  • Cardiopulmonary bypass and myocardial ischemia during on-pump CABG can exacerbate physiological insult in patients with compromised ventricular function.

Purpose of the Study:

  • To evaluate the safety and efficacy of off-pump coronary artery bypass grafting (OPCAB) in patients with poor left ventricular ejection fraction (LVEF).
  • To compare outcomes of OPCAB in patients with poor LVEF versus those with normal LVEF.

Main Methods:

  • Retrospective analysis of non-emergency OPCAB procedures performed by a single surgeon over 18 months.
  • Comparison of two groups: poor LVEF (10%-35%) and normal LVEF (55%-80%).

Related Experiment Videos

  • Analysis of graft number, time to extubation, and length of hospital stay.

    • Main Results:

    • Patients with poor LVEF (mean LVEF 26%) received 2.8 grafts/patient, were extubated in 8.4 hours, and discharged in 4.9 days.
    • Outcomes in the poor LVEF group were statistically equivalent to the normal LVEF group (mean LVEF 63%).
    • No intraaortic balloon pump insertion or mortality was observed in either group.

    Conclusions:

    • Off-pump coronary artery bypass grafting is an effective and safe revascularization strategy for patients with significant left ventricular dysfunction.
    • OPCAB presents a valuable alternative for patients with ischemic cardiomyopathy and reduced LVEF, potentially avoiding the risks associated with cardiopulmonary bypass.